Medicarpin suppresses lung cancer cell growth in vitro and in vivo by inducing cell apoptosis
Lung cancer (LC) is the leading cause of cancer deaths worldwide. Surgery, chemoradiotherapy, targeted therapy, and immunotherapy are considered dominant treatment strategies for LC in the clinic. However, drug resistance and meta-stasis are two major challenges in cancer therapies. Medicarpin (MED)...
Main Authors: | Shen Zongyi, Yin Liqi, Chang Manxia, Wang Haifeng, Hao Mingxuan, Liang Youfeng, Guo Rui, Bi Ying, Wang Jiansong, Yu Changyuan, Li Jinmei, Zhai Qiongli, Cheng Runfen, Zhang Jinku, Sun Jirui, Yang Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2024-03-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.2478/acph-2024-0006 |
Similar Items
-
Medicarpin induces G1 arrest and mitochondria-mediated intrinsic apoptotic pathway in bladder cancer cells
by: Chen Yuan, et al.
Published: (2023-06-01) -
Heterologous biosynthesis of medicarpin using engineered Saccharomyces cerevisiae
by: Chujie Lu, et al.
Published: (2023-12-01) -
Metabolites of Medicarpin and Their Distributions in Rats
by: Hong-Yan Wang, et al.
Published: (2019-05-01) -
Medicarpin and Homopterocarpin Isolated from <i>Canavalia lineata</i> as Potent and Competitive Reversible Inhibitors of Human Monoamine Oxidase-B
by: Jong Min Oh, et al.
Published: (2022-12-01) -
Antimutagenic components in Spatholobus suberectus Dunn against N-methyl-N-nitrosourea
by: Keiko Inami, et al.
Published: (2019-12-01)